ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders.

ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders.

J Atten Disord. 2016 Mar 31;

Authors: Notzon D, Pavlicova M, Glass A, Mariani J, Mahony A, Brooks D, Levin F

Abstract
OBJECTIVE: To estimate the prevalence of ADHD and determine an effective screening test for ADHD in a population-seeking treatment for cannabis use disorders.
METHOD: The Conners Adult ADHD Diagnostic Interview forDiagnostic and Statistical Manual of Mental Disorders, Fourth Edition(DSM-IV; CAADID) was used to generate sensitivity and specificity data for ADHD screening tests, which were then administered to 99 participants seeking treatment for cannabis use disorders to estimate ADHD prevalence.
RESULTS: The prevalence estimated from the Wender Utah Rating Scale (WURS) was 45% (sensitivity = 0.88, sensitivity of 0.75), from the Conners Adult ADHD Rating Scale (CAARS) 34% (sensitivity = 0.80, specificity = 0.91), from the WURS + CAARS 36% (sensitivity = 0.71, specificity = 0.95), and from the Adult ADHD Self-Report Scale (ASRS) 46% (sensitivity = 0.61, specificity = 0.86).
CONCLUSION: The prevalence of ADHD in adults seeking treatment for cannabis use disorders is estimated to be between 34% and 46%. The WURS paired with the CAARS provides excellent sensitivity and specificity for the diagnosis of ADHD in this population.

PMID: 27033880 [PubMed – as supplied by publisher]

via http://www.ncbi.nlm.nih.gov/pubmed/27033880?dopt=Abstract